Back to Browse Journals » Clinical Ophthalmology » Volume 7

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma

Authors Liu Y, Mao W

Published Date December 2012 Volume 2013:7 Pages 7—14

DOI http://dx.doi.org/10.2147/OPTH.S30951

Received 11 October 2012, Accepted 20 November 2012, Published 21 December 2012

Yang Liu, Weiming Mao

Department of Cell Biology and Anatomy, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX

Abstract: Glaucoma is a leading cause of visual loss worldwide. Current antiglaucoma therapy focuses on lowering intraocular pressure to a safe level. In recent years, prostaglandin analogs have become the first-line agents for treating open angle glaucoma. Tafluprost, which was first reported in 2003, is a novel prostaglandin analog, and has been shown to be a potent ocular hypotensive agent in a number of preclinical and clinical studies. Also, its unique preservative-free formulation helps to decrease preservative-associated ocular disorders and improve patient compliance. In this review, studies from 2003 to 2012 focusing on the structure, metabolism, efficacy, and safety of tafluprost are summarized. These studies suggested that application of tafluprost once daily is a safe and effective treatment for patients with open angle glaucoma.

Keywords: tafluprost, prostaglandin analog, glaucoma, intraocular pressure, preservative-free formulation

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Development of a novel disposable lid speculum with a drape

Urano T, Kasaoka M, Yamakawa R, Tamai Y, Nakamura S

Clinical Ophthalmology 2013, 7:1575-1580

Published Date: 5 August 2013

Diamond burr superficial keratectomy with mitomycin C for corneal scarring and high corneal astigmatism after pterygium excision

Ozgurhan EB, Kara N, Yildirim A, Alkin Z, Bozkurt E, Demirok A

Clinical Ophthalmology 2013, 7:951-954

Published Date: 24 May 2013

Surgical outcomes in phacoemulsification after application of a risk stratification system

Tsinopoulos IT, Lamprogiannis LP, Tsaousis KT, Mataftsi A, Symeonidis C, Chalvatzis NT, Dimitrakos SA

Clinical Ophthalmology 2013, 7:895-899

Published Date: 16 May 2013

Long-term retinal nerve fiber layer changes following nonarteritic anterior ischemic optic neuropathy

Dotan G, Goldstein M, Kesler A, Skarf B

Clinical Ophthalmology 2013, 7:735-740

Published Date: 17 April 2013

Clinical manifestations of optic pit maculopathy as demonstrated by spectral domain optical coherence tomography

Tzu JH, Flynn Jr HW, Berrocal AM, Smiddy WE, Murray TG, Fisher YL

Clinical Ophthalmology 2013, 7:167-172

Published Date: 18 January 2013

A characteristic optic disc appearance associated with myopia in subjects with Graves' ophthalmopathy and in subjects with primary open-angle glaucoma

Yamazaki S, Inoue R, Tsuboi T, Kozaki A, Inoue T, Inoue T, Inoue Y

Clinical Ophthalmology 2013, 7:47-53

Published Date: 7 January 2013

Giant cell arteritis: the importance of immediate and appropriate diagnosis and treatment for better prognosis

Pacella F, Mazzeo F, Giorgi D, Cerutti F, Impallara D, Cuozzo G, Soldini M, Pacella E

Clinical Ophthalmology 2012, 6:909-913

Published Date: 13 June 2012